Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia
2020 ◽
Vol 10
(6)
◽
pp. 6597-6609
1971 ◽
Vol 127
(2)
◽
pp. 278-284
◽
Keyword(s):
1998 ◽
Vol 31
(2)
◽
pp. 291A
Keyword(s):